Benzinga | Nov 5, 2020 05:25PM EST

Chembio Diagnostics Q3 EPS $(0.28) Misses $(0.26) Estimate, Sales $10.30M Beat $3.91M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 27.27 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $10.30 million which beat the analyst consensus estimate of $3.91 million by 163.43 percent. This is a 5.96 percent increase over sales of $9.72 million the same period last year.